NICORETTE MICROTAB nicotine 2mg sublingual tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

nicotine betadex complex, Quantity: 17.1 mg (Equivalent: nicotine, Qty 2 mg)

Disponibbli minn:

Johnson & Johnson Pacific Pty Ltd

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: betadex; magnesium stearate; crospovidone; colloidal anhydrous silica

Rotta amministrattiva:

Sublingual

Unitajiet fil-pakkett:

100, 30

Tip ta 'preskrizzjoni:

Not Scheduled after consideration by Committee

Indikazzjonijiet terapewtiċi:

For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit.

Sommarju tal-prodott:

Visual Identification: A white to off-white flat round bevel-edged tablet with a diameter of 6mm, engraved "Nic" on one side and "2" on the opposite side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2001-11-27